Honest Comparison · June 2026
REMEVi vs. Medvi
We compared pricing, plans, language support, and trust across both platforms — based on publicly available data as of June 2026. Here's exactly what we found.
Side-by-side
REMEVi vs. Medvi feature by feature
Based on publicly available data, pricing pages, and patient reviews — June 2026.
| Feature | REMEVi | Medvi |
|---|---|---|
| Semaglutide — lowest advertised | ✅ $149 first month, then $279/mo ($199/mo on 52-wk plan) — all-inclusive | ~$299/mo ($179 first month) |
| Tirzepatide — lowest advertised | ✅ $249 first month, then $379/mo ($269/mo on 52-wk plan) | ~$399/mo ($279 first month) |
| Lowest price requires long prepay? | ✅ No — monthly option, cancel anytime | ✅ No — month-to-month |
| Separate membership fee | ✅ None — care, meds & shipping bundled | ✅ None for compounded plans |
| Spanish-language support | ✅ Fully bilingual (built-in) | ❌ No Spanish support found (Jun 2026) |
| Bilingual care coordinator | ✅ Assigned to every patient | ❌ Not offered |
| LegitScript certified | ✅ Certified | — Verify on site |
| All-inclusive price | ✅ Yes — one all-inclusive price | ✅ Yes |
Pricing and features subject to change. Always verify current pricing on each provider's website.
The bilingual difference
Built bilingual — not retrofitted
REMEVi was built bilingual from the ground up. Every intake form, provider note, care coordinator message, and patient touchpoint is available in fluent English and Spanish.
GLP-1 programs
How the GLP-1 programs compare
Both REMEVi and Medvi offer compounded semaglutide and tirzepatide for weight loss. The active pharmaceutical ingredients are the same — what differs is the experience around the medication: pricing structure, care team access, language support, and response time.
On pricing: REMEVi's semaglutide is $149 for your first month ($130 welcome discount applied automatically at checkout), then $279/month month-to-month — or $199/month on the 52-week plan — all-inclusive. Medvi advertises a low first-month price (around $179), but ongoing compounded refills are reported at approximately $299/month for semaglutide and $399/month for tirzepatide — higher than REMEVi's ongoing rate, and without REMEVi's 52-week savings. Always verify current pricing directly on each provider's site, as telehealth pricing changes frequently.
On support: REMEVi assigns every patient a dedicated bilingual care coordinator with a 2-hour response target. For patients managing side effects, dosage questions, or medication concerns in the first weeks of GLP-1 therapy, response time matters significantly.
On language: This is where the platforms diverge. We did not find Spanish-language support on Medvi's site as of June 2026. REMEVi's entire platform — intake forms, clinical summaries, medication instructions, care coordinator communications — is available natively in English and Spanish. For the 62 million Spanish-speaking Americans, this is a fundamental difference in the quality of care they receive.
FAQ
Common questions
Yes. Both REMEVi and Medvi offer compounded semaglutide and tirzepatide for weight loss prescribed by licensed US providers. REMEVi differentiates on transparent all-inclusive pricing with no first-month-only teaser, native bilingual English and Spanish care, a dedicated bilingual care coordinator with a 2-hour response target, and licensing in all 50 states plus DC. If those matter to you, REMEVi is a strong alternative.
On the ongoing price, yes. Medvi advertises a low first-month price (around $179), but ongoing compounded refills are reported at approximately $299/month for semaglutide and $399/month for tirzepatide. REMEVi's first month is $149 for semaglutide and $249 for tirzepatide ($130 welcome discount applied automatically at checkout), then $279/month and $379/month respectively — or $199/$269 on the 52-week plan — all-inclusive. Always verify current pricing on each provider's website.
No. Based on Medvi's publicly advertised pricing as of June 2026, $179 is a first-month price; ongoing semaglutide refills are reported around $299/month (tirzepatide around $399/month). Confirm the current first-month and recurring prices directly on Medvi's site before deciding.
We did not find Spanish-language support on Medvi's site as of June 2026. REMEVi is built natively bilingual — every intake form, care coordinator, and patient message is available in English and Spanish from day one.
Medvi is an established telehealth provider; you can review its current certifications and patient reviews through public records. REMEVi is LegitScript certified, licensed in all 50 states plus DC, and assigns a bilingual care coordinator to every patient with a 2-hour response target. We encourage comparing current, verifiable information for both before deciding.
Yes. Complete REMEVi's 5-minute intake form, a licensed provider reviews your case within 24 hours, and your medication ships within days. You do not need to formally cancel Medvi before starting — simply time your transition to avoid overlapping charges. Compounded medications are non-FDA-approved preparations prepared by state-licensed compounding pharmacies and are not generic versions of, nor the same as, Ozempic®, Wegovy®, Mounjaro®, or Zepbound®.
Compare REMEVi with other GLP-1 providers
See how REMEVi stacks up on price, bilingual support, and transparency.
Ready to get started with REMEVi?
Clinical review in 24 hours. No insurance needed. $149 for your first month, then $279/mo ($199/mo on 52-week plan), all-inclusive.
See if you qualify